Edgewise Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:EWTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
03 Apr 25	BuyUS$10,000,000	OrbiMed Advisors LLC	Company	496,771	US$20.13
20 Sep 24	SellUS$23,024,412	Novo Holdings A/S	Company	794,530	US$29.13
20 Sep 24	SellUS$829,686	R. Carruthers	Individual	29,024	US$28.59
20 Sep 24	SellUS$202,603	Joanne Donovan	Individual	7,162	US$28.29

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EWTX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	560,430	0.533%
General Public	1,153,259	1.1%
Hedge Funds	6,155,940	5.85%
VC/PE Firms	24,161,958	23%
Institutions	73,168,634	69.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.5%	OrbiMed Advisors LLC	15,252,867	US$225.4m	1.54%	3.67%
8.47%	RA Capital Management, L.P.	8,909,091	US$131.7m	0%	2.03%
6.16%	BlackRock, Inc.	6,485,008	US$95.8m	0.09%	no data
5.85%	Baker Bros. Advisors LP	6,155,940	US$91.0m	5.41%	0.78%
4.91%	Perceptive Advisors LLC	5,164,487	US$76.3m	92.3%	2.69%
4.75%	Novo Holdings A/S	5,000,000	US$73.9m	-9.91%	0.08%
4.74%	Janus Henderson Group plc	4,983,940	US$73.7m	9.33%	0.03%
4.5%	Paradigm Biocapital Advisors LP	4,738,929	US$70.0m	5.45%	3.09%
4.08%	The Vanguard Group, Inc.	4,294,404	US$63.5m	-3.86%	no data
3.24%	Cormorant Asset Management, LP	3,406,534	US$50.3m	0%	3.96%
2.22%	Braidwell LP	2,332,196	US$34.5m	19.1%	1.82%
1.98%	Deerfield Management Company, L.P. Series C	2,078,509	US$30.7m	16.7%	0.68%
1.63%	State Street Global Advisors, Inc.	1,715,545	US$25.4m	1.81%	no data
1.57%	Geode Capital Management, LLC	1,655,664	US$24.5m	3.44%	no data
1.42%	Driehaus Capital Management LLC	1,493,791	US$22.1m	-23.5%	0.13%
1.36%	Bellevue Asset Management AG	1,428,929	US$21.1m	0%	0.31%
1.21%	Frazier Life Sciences Management, LP	1,271,245	US$18.8m	-55.1%	0.84%
1.16%	Viking Global Investors LP	1,224,986	US$18.1m	-17.3%	0.06%
1.03%	MPM BioImpact LLC	1,079,316	US$16.0m	17.7%	2.55%
1.02%	Artisan Partners Limited Partnership	1,071,596	US$15.8m	7.09%	0.01%
0.98%	New Leaf Venture Partners, LLC	1,030,161	US$15.2m	0%	44.66%
0.85%	Millennium Management LLC	888,968	US$13.1m	-9.94%	0.01%
0.74%	First Light Asset Management, LLC	780,639	US$11.5m	0%	1.38%
0.74%	American Century Investment Management Inc	779,766	US$11.5m	1.22%	0.01%
0.7%	Artal Group S.A.	734,343	US$10.9m	81.7%	0.38%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/17 03:24
End of Day Share Price	2025/05/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Edgewise Therapeutics, Inc. is covered by 11 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Cory Kasimov	Evercore ISI
Paul Choi	Goldman Sachs
Debjit Chattopadhyay	Guggenheim Securities, LLC